Zavesca and Calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zavesca (miglustat) and Calcium (calcium). Common drug interactions include bladder disorder among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Zavesca and Calcium. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Zavesca?

Zavesca has active ingredients of miglustat. eHealthMe is studying from 1,208 Zavesca users. Check the latest studies of Zavesca.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,203 Calcium users. Check the latest studies of Calcium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

25 people who take Zavesca and Calcium together, and have interactions are studied.

What are the common drug interactions of Zavesca and Calcium, by gender? *:

female:

Bladder disorder
Cystitis (inflammation of the wall of the bladder)
Dehydration (dryness resulting from the removal of water)
Pneumonia
Renal failure (kidney dysfunction)
Urinary tract infection
Escherichia test positive
General physical health deterioration (weak health status)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Flatulence (flatus expelled through the anus)

male:

Dyspnoea (difficult or laboured respiration)
Oxygen saturation decreased
Bone pain
Cerebral haemorrhage (bleeding within the brain)
Contusion (a type of hematoma of tissue in which capillaries)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dizziness
Eye haemorrhage (bleeding in the eye)
Fall
Fatigue (feeling of tiredness)

What are the common drug interactions of Zavesca and Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Dyspnoea (difficult or laboured respiration)
Oxygen saturation decreased
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Pyrexia (fever)
Respiratory distress (difficulty in breathing)
Arthralgia (joint pain)
Malaise (a feeling of general discomfort or uneasiness)
Upper respiratory tract infection
Death
Constipation

10-19:

Pneumonia
Flatulence (flatus expelled through the anus)
Mass
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)

20-29:

n/a

30-39:

Bladder disorder
Cystitis (inflammation of the wall of the bladder)
Dehydration (dryness resulting from the removal of water)
Renal failure (kidney dysfunction)
Escherichia test positive
General physical health deterioration (weak health status)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Urinary tract infection
Bladder dilatation
Device dislocation

40-49:

n/a

50-59:

Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Dysgraphia (impaired ability to learn to write)
Fine motor delay (delayed movements and actions of the muscles)
Nerve compression
Spinal osteoarthritis (joint cartilage loss in spine)

60+:

Asthenia (weakness)
Pain
Dizziness
Dyspnoea (difficult or laboured respiration)
Eye haemorrhage (bleeding in the eye)
Fall
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Oxygen saturation decreased
Pain in extremity

What are the existing conditions these people have? *

Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 4 people, 16.00%
Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zavesca and Calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously